EMAT vs TECH · rev $1.6M vs P/E 65, rev $1.22B
Evolution Metals & Technologies Corp. Common Stock (EMAT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Evolution Metals & Technologies Corp. Common Stock (EMAT) is a other industrial metals & mining company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EMAT revenue for 2026-06-30 was $1.6M. Net income was -$11.9M. Revenue was down 12.9% from 2026-03-31 to 2026-06-30. EMAT currently screens at market cap $4.30B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EMAT currently screens at market cap $4.30B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EMAT and TECH stock pages for the full models.
Not investment advice.